Eric J Ende - Net Worth and Insider Trading
Eric J Ende Net Worth
The estimated net worth of Eric J Ende is at least $3 Million dollars as of 2024-11-05. Eric J Ende is the Director of Avadel Pharmaceuticals PLC and owns about 167,900 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $3 Million. Eric J Ende is also the Director of Matinas BioPharma Holdings Inc and owns about 2,186 shares of Matinas BioPharma Holdings Inc (MTNB) stock worth over $1,164. Details can be seen in Eric J Ende's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric J Ende has not made any transactions after 2023-05-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric J Ende
Eric J Ende Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric J Ende owns 4 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , Matinas BioPharma Holdings Inc (MTNB) , and Progenics Pharmaceuticals Inc (PGNX) among others .
Click here to see the complete history of Eric J Ende’s form 4 insider trades.
Insider Ownership Summary of Eric J Ende
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2023-05-18 | director |
| MTNB | Matinas BioPharma Holdings Inc | 2019-08-20 | director |
| PGNX | Progenics Pharmaceuticals Inc | 2020-06-19 | director |
 | | 2022-01-01 | director |
Eric J Ende Latest Holdings Summary
Eric J Ende currently owns a total of 2 stocks. Among these stocks, Eric J Ende owns 167,900 shares of Avadel Pharmaceuticals PLC (AVDL) as of May 18, 2023, with a value of $3 Million and a weighting of 99.95%. Eric J Ende also owns 2,186 shares of Matinas BioPharma Holdings Inc (MTNB) as of August 20, 2019, with a value of $1,164 and a weighting of 0.05%.
Latest Holdings of Eric J Ende
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2023-05-18 | 167,900 | 15.00 | 2,518,500 |
| MTNB | Matinas BioPharma Holdings Inc | 2019-08-20 | 2,186 | 0.53 | 1,164 |
Holding Weightings of Eric J Ende
Eric J Ende Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric J Ende has made a total of 9 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Avadel Pharmaceuticals PLC is the acquisition of 13,000 shares on May 18, 2023, which cost Eric J Ende around $181,090.
According to the SEC Form 4 filings, Eric J Ende has made a total of 0 transactions in Matinas BioPharma Holdings Inc (MTNB) over the past 5 years. The most-recent trade in Matinas BioPharma Holdings Inc is the acquisition of 400 shares on August 20, 2019, which cost Eric J Ende around $13,200.
Insider Trading History of Eric J Ende
- 1
Eric J Ende Trading Performance
GuruFocus tracks the stock performance after each of Eric J Ende's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric J Ende is 57.25%. GuruFocus also compares Eric J Ende's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric J Ende within 3 months outperforms 8 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric J Ende's insider trading performs compared to the benchmark.
Performance of Eric J Ende
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.23 | | | | | |
| Relative Return to S&P 500(%) | -2.29 | | | | | |
Eric J Ende Ownership Network
Ownership Network List of Eric J Ende
Ownership Network Relation of Eric J Ende
Eric J Ende Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Eric J Ende is the director of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Eric J Ende made 1 insider transaction in Avadel Pharmaceuticals PLC (AVDL) with a net purchase of 13,000. Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 43,500 shares were bought by its insiders, resulting in a net sale of 60,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Eric J Ende Mailing Address
Above is the net worth, insider trading, and ownership report for Eric J Ende. You might contact Eric J Ende via mailing address: C/o Matinas Biopharma Holdings, Inc., 1545 Route 206 South, Suite 302, Bedminster Nj 07921.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
